Form 4: Director Marion Ann Snyder Increases Stake in Spectral AI

Director Marion Ann Snyder acquired 25,000 shares of Spectral AI common stock through the vesting of restricted stock units.

Summary

• Director Marion Ann Snyder received 25,000 shares of common stock on April 24, 2026.
• The acquisition resulted from the vesting of restricted stock units (RSUs).
• The reporting person now holds 25,000 shares of common stock directly.
• The filing also details existing holdings of non-qualified stock options (NQSOs) with various exercise prices.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine disclosure of director equity compensation that does not signal a change in company strategy or financial health.

Positives

• Director alignment with shareholder interests through increased equity ownership.
• Full vesting of the reported 25,000 RSU grant.

Negatives

• None identified in this filing.

Risks

• Future share price volatility affecting the value of vested equity.
• Market risks associated with the exercise prices of existing NQSOs ($1.25 to $1.67).

Future Outlook

The filing indicates that the remaining 50% of the reported RSUs are scheduled to vest on April 1, 2027.

Industry Context

StockSavvy.ai notes that director equity acquisitions are standard corporate governance practices, signaling internal confidence in the company's long-term trajectory within the medical technology sector.

Comparison to Industry Standards

• The use of RSU and NQSO compensation structures is consistent with standard executive and director compensation packages for small-cap medical technology firms.
• The reporting of equity changes via Form 4 is a standard regulatory requirement for all publicly traded U.S. companies.

Stakeholder Impact

• Increased alignment between the director and shareholders.

Next Steps

• Vesting of the remaining 50% of RSUs on April 1, 2027.

Key Dates

Keywords

Spectral AI, MDAI, Insider Trading, Form 4, Director Ownership, Equity Compensation